Clinical trial
The Efficacy of Dual-target iTBS in Youth With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT07084649 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of Dual-target iTBS in Youth With Attention-Deficit/Hyperactivity Disorder (ADHD)
- Lead sponsor
- Shanghai Mental Health Center
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- January 1, 2025
- Completion date
- December 30, 2026
- Enrollment
- 15 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adhd